Recommended Workup and Initial Management for Suspected Sarcoma
Any unexplained deep soft tissue mass or superficial lesion ≥5 cm must be immediately referred to a specialized sarcoma reference center before any intervention, as this single step most dramatically impacts outcomes and prevents the catastrophic consequences of inappropriate initial surgery 1.
Immediate Referral Criteria
Refer urgently to a sarcoma center if ANY of the following:
- Deep soft tissue mass (regardless of size)
- Superficial mass ≥5 cm
- Any mass that is enlarging, painful, or has atypical features
Critical Pitfall: Do NOT perform excisional biopsy or unplanned excision outside a sarcoma center—inadvertent positive margins from non-specialist surgery substantially increase local recurrence risk and worsen survival 2. The discrepancy rate between outside diagnoses and specialized sarcoma pathologists ranges from 8-11% for major errors 1.
Imaging Workup at Sarcoma Center
Primary Tumor Imaging
- Extremities/pelvis/trunk: MRI is the primary modality 1
- Retroperitoneal sarcomas: CT or MRI (equivalent performance) 1
- Calcified lesions: CT preferred 1
- Standard radiographs: Useful to exclude bone tumor, detect erosion/fracture risk, show calcifications 1
Note on ultrasound: While recent data shows 95.3% sensitivity and 100% specificity for characterizing lipomas 3, this applies only to clearly low-risk superficial lesions. For suspected sarcomas, ultrasound alone is insufficient—proceed directly to MRI/CT 1.
Additional Staging
- FDG-PET/CT: Consider when preoperative treatment is an option, as it helps estimate malignancy grade alongside pathology 1
Biopsy Technique (Performed at Sarcoma Center Only)
Standard approach: Multiple core needle biopsies using 14-16 gauge needles 1
Alternative approaches:
- Excisional biopsy: Only for superficial lesions <3 cm 1
- Open biopsy: Selected cases only, decided by multidisciplinary team 1
Critical Biopsy Planning Requirements
- Must be performed by surgeon or radiologist after multidisciplinary discussion 1
- Plan biopsy tract so it can be completely removed during definitive surgery (except retroperitoneal sarcomas) 1
- Consider tattooing the biopsy entrance point 1
- Obtain informed consent for biobanking of fresh frozen tissue for molecular diagnostics 1
- Immediate frozen section evaluation may confirm tissue adequacy but should NOT be used for diagnosis 1
Important caveat: Biopsy may underestimate tumor grade, so integrate radiological findings (including PET) with pathology when planning preoperative treatment 1.
Multidisciplinary Team Requirements
Management must involve 1:
- Pathologists (specialized in sarcoma)
- Radiologists
- Surgical oncologists
- Orthopedic oncologists
- Radiation oncologists
- Medical oncologists
- Nuclear medicine specialists (as needed)
The center should have:
- Weekly multidisciplinary tumor board meetings
- High case volume
- State-of-the-art molecular pathology
- Active clinical trial enrollment
- Published outcomes data
Why Specialized Centers Matter
Management at sarcoma reference centers is a Level III, Grade A recommendation 1. These centers treat high patient volumes annually, participate in ongoing clinical trials, and have the multidisciplinary expertise essential for optimal outcomes. The heterogeneity of sarcoma subtypes (most have incidence <2 per million) means individual practitioners rarely accumulate sufficient experience 1.
The evidence strongly supports that early referral—before any biopsy or intervention—is the single most impactful measure to optimize oncological outcomes 2.